UPDATE 1-Hikma raises full-year revenue forecast
November 06, 2014 at 03:26 AM EST
Nov 6 (Reuters) - Drugmaker Hikma Pharmaceuticals Plc raised its full-year revenue growth target to 7 percent, citing strong demand for its high-margin injectible drugs, particularly in the United States.
